HAO:NSD-Haoxi Health Technology Limited Class A Ordinary Shares (USD)

COMMON STOCK | Advertising Agencies |

Last Closing

USD 1.5452

Change

+0.24 (+18.30)%

Market Cap

N/A

Volume

1.56K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap
ADVWW Advantage Solutions Inc

N/A

USD 3.69B
CRTO Criteo Sa

-0.05 (-0.18%)

USD 1.58B
STGW Stagwell Inc

-0.06 (-1.02%)

USD 1.57B
MGNI Magnite Inc

+0.10 (+0.81%)

USD 1.38B
ZD Ziff Davis Inc

+0.18 (+0.57%)

USD 1.37B
IAS Integral Ad Science Holding LL..

+0.11 (+1.51%)

USD 1.10B
QNST QuinStreet Inc

+0.54 (+3.04%)

USD 0.88B
NCMI National CineMedia Inc

-0.67 (-11.55%)

USD 0.54B
NEXN Nexxen International Ltd

+0.07 (+0.64%)

USD 0.49B
ADV Advantage Solutions Inc

+0.01 (+0.78%)

USD 0.42B

ETFs Containing HAO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Advertising Agencies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -56.41% 13% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.41% 13% F 9% A-
Trailing 12 Months  
Capital Gain -99.21% 4% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.21% 4% F 1% F
Trailing 5 Years  
Capital Gain -99.75% 8% B- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.75% 8% B- 2% F
Average Annual (5 Year Horizon)  
Capital Gain -16.51% 31% F 16% F
Dividend Return -16.51% 31% F 16% F
Total Return N/A 50% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 34.57% 72% C 52% F
Risk Adjusted Return -47.76% 34% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.